Hims & Hers Health (NYSE:HIMS) Trading Down 4.2%

Hims & Hers Health, Inc. (NYSE:HIMS)’s share price dropped 4.2% during mid-day trading on Thursday . The stock traded as low as $8.40 and last traded at $8.47. Approximately 23,207 shares changed hands during trading, a decline of 98% from the average daily volume of 1,516,071 shares. The stock had previously closed at $8.84.

A number of research analysts have commented on the stock. Truist Financial initiated coverage on shares of Hims & Hers Health in a research note on Wednesday, April 21st. They issued a “hold” rating on the stock. Zacks Investment Research raised Hims & Hers Health from a “sell” rating to a “hold” rating in a research note on Wednesday, May 19th. Truist Securities initiated coverage on Hims & Hers Health in a research note on Wednesday, April 21st. They issued a “hold” rating and a $12.00 target price on the stock. upped their price target on Hims & Hers Health from $16.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, May 19th. Finally, Credit Suisse Group raised Hims & Hers Health from a “neutral” rating to an “outperform” rating in a report on Wednesday, May 26th. Six investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Hims & Hers Health presently has a consensus rating of “Hold” and a consensus price target of $15.71.

The business has a 50-day moving average price of $11.41. The company has a market cap of $1.54 billion, a PE ratio of -36.04 and a beta of -0.12.

Hims & Hers Health (NYSE:HIMS) last issued its quarterly earnings results on Monday, May 17th. The company reported ($0.14) EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. The firm had revenue of $52.31 million for the quarter, compared to analysts’ expectations of $48.74 million. As a group, equities research analysts expect that Hims & Hers Health, Inc. will post -0.58 earnings per share for the current year.

A number of large investors have recently modified their holdings of the business. Disruptive Technology Advisers LLC acquired a new position in shares of Hims & Hers Health during the 1st quarter valued at about $121,538,000. Franklin Resources Inc. purchased a new stake in shares of Hims & Hers Health during the 1st quarter worth about $57,201,000. Oaktree Capital Management LP purchased a new position in Hims & Hers Health in the first quarter valued at approximately $49,923,000. Ameriprise Financial Inc. acquired a new position in Hims & Hers Health during the first quarter valued at approximately $25,260,000. Finally, BlackRock Inc. purchased a new stake in Hims & Hers Health during the first quarter worth approximately $19,274,000. 37.00% of the stock is currently owned by hedge funds and other institutional investors.

About Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care.

Recommended Story: Channel Trading

Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.